These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 29038345)

  • 61. The clock gene brain and muscle Arnt-like protein-1 (BMAL1) is involved in hair growth.
    Watabe Y; Tomioka M; Watabe A; Aihara M; Shimba S; Inoue H
    Arch Dermatol Res; 2013 Oct; 305(8):755-61. PubMed ID: 23955654
    [TBL] [Abstract][Full Text] [Related]  

  • 62. c-MYC targets the central oscillator gene Per1 and is regulated by the circadian clock at the post-transcriptional level.
    Repouskou A; Prombona A
    Biochim Biophys Acta; 2016 Apr; 1859(4):541-52. PubMed ID: 26850841
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Timing of expression of the core clock gene Bmal1 influences its effects on aging and survival.
    Yang G; Chen L; Grant GR; Paschos G; Song WL; Musiek ES; Lee V; McLoughlin SC; Grosser T; Cotsarelis G; FitzGerald GA
    Sci Transl Med; 2016 Feb; 8(324):324ra16. PubMed ID: 26843191
    [TBL] [Abstract][Full Text] [Related]  

  • 64. EGR1 regulates hepatic clock gene amplitude by activating Per1 transcription.
    Tao W; Wu J; Zhang Q; Lai SS; Jiang S; Jiang C; Xu Y; Xue B; Du J; Li CJ
    Sci Rep; 2015 Oct; 5():15212. PubMed ID: 26471974
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Core Circadian Clock Genes Regulate Leukemia Stem Cells in AML.
    Puram RV; Kowalczyk MS; de Boer CG; Schneider RK; Miller PG; McConkey M; Tothova Z; Tejero H; Heckl D; Järås M; Chen MC; Li H; Tamayo A; Cowley GS; Rozenblatt-Rosen O; Al-Shahrour F; Regev A; Ebert BL
    Cell; 2016 Apr; 165(2):303-16. PubMed ID: 27058663
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Identification of Circadian Determinants of Cancer Chronotherapy through In Vitro Chronopharmacology and Mathematical Modeling.
    Dulong S; Ballesta A; Okyar A; Lévi F
    Mol Cancer Ther; 2015 Sep; 14(9):2154-64. PubMed ID: 26141947
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Proliferative Glioblastoma Cancer Cells Exhibit Persisting Temporal Control of Metabolism and Display Differential Temporal Drug Susceptibility in Chemotherapy.
    Wagner PM; Sosa Alderete LG; Gorné LD; Gaveglio V; Salvador G; Pasquaré S; Guido ME
    Mol Neurobiol; 2019 Feb; 56(2):1276-1292. PubMed ID: 29881948
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Novel mouse model for evaluating in vivo efficacy of xCT inhibitor.
    Yoshioka R; Fujieda Y; Suzuki Y; Kanno O; Nagahira A; Honda T; Murakawa M; Yukiura H
    J Pharmacol Sci; 2019 Jul; 140(3):242-247. PubMed ID: 31421954
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Pharmacological modulators of the circadian clock as potential therapeutic drugs: focus on genotoxic/anticancer therapy.
    Antoch MP; Kondratov RV
    Handb Exp Pharmacol; 2013; (217):289-309. PubMed ID: 23604484
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Chronotherapy with defective circadian clock?
    Zhang Y; Lévi F; Chang Y
    Aging (Albany NY); 2018 Apr; 10(4):520-521. PubMed ID: 29695639
    [No Abstract]   [Full Text] [Related]  

  • 71. The mammalian clock and chronopharmacology.
    Griffett K; Burris TP
    Bioorg Med Chem Lett; 2013 Apr; 23(7):1929-34. PubMed ID: 23481644
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Circadian clock, cancer, and chemotherapy.
    Sancar A; Lindsey-Boltz LA; Gaddameedhi S; Selby CP; Ye R; Chiou YY; Kemp MG; Hu J; Lee JH; Ozturk N
    Biochemistry; 2015 Jan; 54(2):110-23. PubMed ID: 25302769
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Inhibiting system x
    Clemons NJ; Liu DS; Duong CP; Phillips WA
    Mol Cell Oncol; 2017; 4(5):e1344757. PubMed ID: 29057306
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cancer "Clock" Opens New Therapeutic Avenues.
    Cancer Discov; 2017 Dec; 7(12):1358. PubMed ID: 29079690
    [TBL] [Abstract][Full Text] [Related]  

  • 75. SLC7A11, a component of cysteine/glutamate transporter, is a novel biomarker for the diagnosis and prognosis in laryngeal squamous cell carcinoma.
    Ma Z; Zhang H; Lian M; Yue C; Dong G; Jin Y; Li R; Wan H; Wang R; Wang Y; Zhai J; Ma H; Feng L; Han J; Liu S; Guo Y; Li J; Liu Y; Fang J; Liu H
    Oncol Rep; 2017 Nov; 38(5):3019-3029. PubMed ID: 29048627
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Periodic variation in bile acids controls circadian changes in uric acid via regulation of xanthine oxidase by the orphan nuclear receptor PPARα.
    Kanemitsu T; Tsurudome Y; Kusunose N; Oda M; Matsunaga N; Koyanagi S; Ohdo S
    J Biol Chem; 2017 Dec; 292(52):21397-21406. PubMed ID: 29101234
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Oncogenic PI3K promotes methionine dependency in breast cancer cells through the cystine-glutamate antiporter xCT.
    Lien EC; Ghisolfi L; Geck RC; Asara JM; Toker A
    Sci Signal; 2017 Dec; 10(510):. PubMed ID: 29259101
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Combination Therapy with Sulfasalazine and Valproic Acid Promotes Human Glioblastoma Cell Death Through Imbalance of the Intracellular Oxidative Response.
    Garcia CG; Kahn SA; Geraldo LHM; Romano I; Domith I; Silva DCLE; Dos Santos Assunção F; Ferreira MJ; Portugal CC; de Souza JM; Romão LF; Netto ADP; Lima FRS; Cossenza M
    Mol Neurobiol; 2018 Aug; 55(8):6816-6833. PubMed ID: 29349577
    [TBL] [Abstract][Full Text] [Related]  

  • 79. xCT (SLC7A11)-mediated metabolic reprogramming promotes non-small cell lung cancer progression.
    Ji X; Qian J; Rahman SMJ; Siska PJ; Zou Y; Harris BK; Hoeksema MD; Trenary IA; Heidi C; Eisenberg R; Rathmell JC; Young JD; Massion PP
    Oncogene; 2018 Sep; 37(36):5007-5019. PubMed ID: 29789716
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Optimized Dosing Schedule Based on Circadian Dynamics of Mouse Breast Cancer Stem Cells Improves the Antitumor Effects of Aldehyde Dehydrogenase Inhibitor.
    Matsunaga N; Ogino T; Hara Y; Tanaka T; Koyanagi S; Ohdo S
    Cancer Res; 2018 Jul; 78(13):3698-3708. PubMed ID: 29735553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.